University of Cincinnati Cancer Center first in Midwest to open pancreatic cancer vaccine trial
February 20, 2024
The University of Cincinnati Cancer Center is the first site in the Midwest enrolling patients in a new Phase 2 clinical trial testing a vaccine to treat pancreatic cancer.